Streetbeat News

Regulatory

CGEN

Compugen has announced that the FDA has cleared the Investigational New Drug (IND) application for COM503, a treatment for solid tumors.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 11:04 am

SNDX

The FDA has extended the review period for Syndax Pharmaceuticals' leukemia drug Revumenib by three months, pushing the PDUFA action date to December 26, 2024. This extension is due to the submission of additional information, which was classified as a Major Amendment.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 11:03 am

GH

Guardant Health shares are trading higher after the company announced that its Shield blood test for colorectal cancer screening received FDA approval.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 10:58 am

NLSPW

Trading has been halted for NLSPW at 6:56:51 a.m. ET due to pending news.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 10:57 am

NLSP

Trading for NLSP was halted at 6:56:51 a.m. ET due to pending news.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 10:56 am

ESGR

Trading for a company has been halted at 6:55:00 a.m. ET due to pending news. The company in question is ESGR.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 10:55 am

ESGRP

Trading for ESGRP has been halted as of 6:55:00 a.m. ET pending news. Investors should stay tuned for further updates.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 10:55 am

ESGRO

Trading in ESGRO has been halted as of 6:55:00 a.m. ET pending news. Investors should stay tuned for further updates.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 10:55 am

CGTX

Trading for CGTX was halted at 6:55:00 a.m. ET due to pending news.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 10:55 am

AMRN

HLS Therapeutics has entered into a Product Listing Agreement with the Province of Alberta for the listing and public reimbursement of Amarin's Vascepa, effective August 1, 2024. Vascepa will be reimbursed for secondary prevention of cardiovascular events in statin-treated patients with established cardiovascular disease and elevated triglycerides.

Portfolio Pulse from Benzinga Newsdesk

July 29, 2024 | 10:50 am